Via EDGAR
July 27, 2018
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: | Ms. Amanda Ravitz |
Re: | Bionano Genomics, Inc. |
Registration Statement on Form S-1
File No. 333-225970
Acceleration Request
Requested Date: Tuesday, July 31, 2018
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the Registrant) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-1 (File No. 333-225970) (the Registration Statement) to become effective on July 31, 2018, at 4:00 P.M., Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. This request for acceleration is subject, however, to your receiving a telephone call prior to such time from our legal counsel, Cooley LLP, confirming this request. The Registrant hereby authorizes James Pennington of Cooley LLP to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with James Pennington of Cooley LLP, counsel to the Registrant, at (858) 550-6029.
Very truly yours, | ||
Bionano Genomics, Inc. | ||
By: | /s/ R. Erik Holmlin, Ph.D. | |
R. Erik Holmlin, Ph.D. | ||
President and Chief Executive Officer |
cc: | Mike Ward, Bionano Genomics, Inc. |
James Pennington, Cooley LLP
Angela Dowd, Loeb & Loeb LLP